E-LIB Suche - Ergebnisse für: Layton, Deborah

1

Updated core competencies in pharmacoepidemiology to inform..:

Osborne, Vicki ; Goodin, Amie ; Brown, Joshua...
Pharmacoepidemiology and Drug Safety. 33 (2024) 4 - p. , 2024

Link: https://doi.org/10.1002/..

2

Use of quantitative bias analysis to evaluate single‐arm tr..:

Gray, Christen ; Ralphs, Eleanor ; Fox, Matthew P....
Pharmacoepidemiology and Drug Safety. 33 (2024) 5 - p. , 2024

Link: https://doi.org/10.1002/..

3

Identification of cardiotoxicity related to non-small cell ..:

Chan, Stefanie Ho Yi ; Khatib, Yasmin ; Webley, Sherael..
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

4

Overview of the European post‐authorisation study register ..:

Sultana, Janet ; Crisafulli, Salvatore ; Almas, Mariana...
Pharmacoepidemiology and Drug Safety. 31 (2022) 6 - p. 689-705 , 2022

Link: https://doi.org/10.1002/..

5

Correction to: A Landscape Analysis of Post-Marketing Studi..:

Pereira, Leonardo Roque ; Durán, Carlos E. ; Layton, Deborah...
Drug Safety. 45 (2022) 4 - p. 399-399 , 2022

Link: https://doi.org/10.1007/..

6

A Landscape Analysis of Post-Marketing Studies Registered i..:

Roque Pereira, Leonardo ; Durán, Carlos E. ; Layton, Deborah...
Drug Safety. 45 (2022) 4 - p. 333-344 , 2022

Link: https://doi.org/10.1007/..

7

A Framework for Methodological Choice and Evidence Assessme..:

Gray, Christen M. ; Grimson, Fiona ; Layton, Deborah..
Drug Safety. 43 (2020) 7 - p. 623-633 , 2020

Link: https://doi.org/10.1007/..

8

List of Contributors:

, In: Post-Authorization Safety Studies of Medicinal Products,

Ali, Ayad K. ; Arana, Alejandro ; Baxter, Roger... - p. xi-xii , 2018

Link: https://doi.org/10.1016/..

9

Safety of Atrovent® CFC-free inhaler: respiratory events re..:

Osborne, Vicki ; Layton, Deborah ; Fogg, Carole..
International Journal of Pharmacy Practice. 26 (2017) 4 - p. 356-363 , 2017

Link: https://doi.org/10.1111/..

10

Drugs and life-threatening ventricular arrhythmia risk: res..:

Coughtrie, Abigail L ; Behr, Elijah R ; Layton, Deborah...
BMJ Open. 7 (2017) 10 - p. e016627 , 2017

Link: https://doi.org/10.1136/..

11

110Working with community pharmacists to improve anticoagul..:

Gordon, Sharron ; Rowse, Vicki ; Williams, Elizabeth..
EP Europace. 19 (2017) suppl_1 - p. i46-i46 , 2017

Link: https://doi.org/10.1093/..

12

Utilisation and Safety of Deferasirox: Results from an Obse..:

Osborne, Vicki ; Davies, Miranda ; Layton, Deborah.
Drug Safety. 41 (2017) 3 - p. 267-275 , 2017

Link: https://doi.org/10.1007/..

13

Vulnerable Patients and Potential Harms: The Contribution o..:

Layton, Deborah
Drug Safety. 39 (2016) 4 - p. 277-280 , 2016

Link: https://doi.org/10.1007/..

14

Safety of Intranasal Quadrivalent Live Attenuated Influenza..:

McNaughton, Rhian ; Lynn, Elizabeth ; Osborne, Vicki...
Drug Safety. 39 (2016) 4 - p. 323-333 , 2016

Link: https://doi.org/10.1007/..

15

Pattern of Onset and Risk Factors for Peripheral Oedema Dur..:

Layton, Deborah ; Coughtrie, Abigail L. ; Qayum, Naseer.
Drug Safety. 39 (2016) 11 - p. 1093-1104 , 2016

Link: https://doi.org/10.1007/..